Quality of life valuations of HPV-associated cancer health states by the general population

Sexually Transmitted Infections

Volumn 88, Issue 7, 2012, Pages 517-521

  Conway, E Lynne ^a   Farmer, K Chip ^b   Lynch, William J ^c   Rees, Guy L ^d   Wain, Gerard ^e   Adams, Jane ^f  

^a CSL Biotherapies   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f Pretium Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVOR; CANCER THERAPY; CONSULTATION; COST EFFECTIVENESS ANALYSIS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PENIS CANCER; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM; VACCINATION; VAGINA CANCER; VIRUS CARCINOGENESIS; VULVA CANCER; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANUS NEOPLASMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PENILE NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; VAGINAL NEOPLASMS; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 84871360218     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050161     Document Type: Article

References (30)

1. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections 3. J Clin Virol 2005;32(Suppl 1):S16-24.
2. Beutels P, Jit M. A brief history of economic evaluation for human papillomavirus vaccination policy. Sex Health 2010;7:352-8.
3. Moscicki AB. Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev 2010;21:347-63, x-xi.
4. Howard K, Salkeld G, McCaffery K, et al . HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility? Health Econ 2008;17:593-605. (Pubitemid 351772340)
5. Myers ER, Green S, Lipkus I. Patient preferences for health states related to HPV infection: visual analog scales vs time trade-off elicitation. Proceedings of 21st International Papillomavirus Conference . Mexico City, Mexico, 2004. Abstract 542.
6. Woodhall SC, Jit M, Soldan K, et al. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex Transm Infect 2011;87:458-63.
7. Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 2009;339:b3884.
8. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008;113:2892-900.
9. Bilimoria KY, Bentrem DJ, Ko CY, et al. Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States. Ann Surg Oncol 2008;15:1948-58.
10. Ryerson AB, Peters ES, Coughlin SS, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008;113:2901-9.
11. NCCN Clinical Practice Guidelines in Oncology - Head and Neck Cancers. National Comprehensive Cancer Network. 2010. http://www.nccn.org/professionals/ physician-gls/PDF/head-and-neck.pdf (accessed Mar 2010).
12. Hernandez BY, Barnholtz-Sloan J, German RR, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer 2008;113:2883-91.
13. Leijte JA, Kirrander P, Antonini N, et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 2008;54:161-8.
14. Falconer AD, Hirschowitz L, Weeks J, et al. The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997-2002). BJOG 2007;114 :391-7. (Pubitemid 46393277)
15. Wu X, Matanoski G, Chen VW, et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 2008;113:2873-82.
16. CancerHelp UK. Vaginal Cancer. Cancer Research UK. 2011. http://www.cancerhelp.org.uk/type/vaginal-cancer/ (accessed May 2011).
17. Jephcott CR, Paltiel C, Hay J. Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors. Clin Oncol (R Coll Radiol) 2004;16:530-5. (Pubitemid 39517661)
18. Ness RM, Holmes AM, Klein R, et al. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol 1999;94:1650-7. (Pubitemid 29260460)
19. Janda M, Obermair A, Cella D, et al. Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer 2004;14:875-81. (Pubitemid 39238174)
20. Likes WM, Stegbauer C, Tillmanns T, et al. Correlates of sexual function following vulvar excision. Gynecol Oncol 2007;105:600-3. (Pubitemid 46734178)
21. Maddineni SB, Lau MM, Sangar VK. Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol 2009;9:8.
22. Murphy BA, Ridner S, Wells N, et al. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 2007;62:251-67. (Pubitemid 46679283)
23. Curran D, Giralt J, Harari PM, et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 2007;25 :2191-7. (Pubitemid 46954642)
24. Fang FM, Tsai WL, Chien CY, et al. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation. Oncology 2005;68:405-13.
25. Pourel N, Peiffert D, Lartigau E, et al. Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 2002;54:742-51.
26. Dolan P. Valuing health-related quality of life. Issues and controversies. Pharmacoeconomics 1999;15 :119-27. (Pubitemid 29093255)
27. Drummond M, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programs . 3rd edn. Oxford: Oxford University Press, 2005.
28. Breetvelt IS, Van Dam FS. Underreporting by cancer patients: the case of response-shift. Soc Sci Med 1991;32:981-7.
29. Beusterien KM, Szabo SM, Kotapati S, et al. Societal preference values for advanced melanoma health states in the United Kingdom and Australia. Br J Cancer 2009;101:387-9.
30. Bernert S, Fernandez A, Haro JM, et al . Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health 2009;12:750-8.